CINEMARK HOLDINGS INC (CNK) Fundamental Analysis & Valuation

NYSE:CNK • US17243V1026

Current stock price

30.37 USD
-0.5 (-1.62%)
At close:
30.3 USD
-0.07 (-0.23%)
After Hours:

This CNK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. CNK Profitability Analysis

1.1 Basic Checks

  • In the past year CNK was profitable.
  • CNK had a positive operating cash flow in the past year.
  • In multiple years CNK reported negative net income over the last 5 years.
  • CNK had a positive operating cash flow in each of the past 5 years.
CNK Yearly Net Income VS EBIT VS OCF VS FCFCNK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M -600M

1.2 Ratios

  • With a decent Return On Assets value of 3.08%, CNK is doing good in the industry, outperforming 77.22% of the companies in the same industry.
  • With an excellent Return On Equity value of 33.69%, CNK belongs to the best of the industry, outperforming 94.94% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 7.53%, CNK belongs to the top of the industry, outperforming 84.81% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CNK is significantly below the industry average of 159.10%.
  • The last Return On Invested Capital (7.53%) for CNK is above the 3 year average (7.42%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.08%
ROE 33.69%
ROIC 7.53%
ROA(3y)4.3%
ROA(5y)-0.12%
ROE(3y)48.19%
ROE(5y)-45.43%
ROIC(3y)7.42%
ROIC(5y)N/A
CNK Yearly ROA, ROE, ROICCNK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200

1.3 Margins

  • CNK has a better Profit Margin (4.38%) than 75.95% of its industry peers.
  • CNK has a better Operating Margin (10.97%) than 75.95% of its industry peers.
  • CNK's Operating Margin has improved in the last couple of years.
  • CNK has a better Gross Margin (64.13%) than 70.89% of its industry peers.
  • CNK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.97%
PM (TTM) 4.38%
GM 64.13%
OM growth 3Y51.8%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5Y-0.48%
CNK Yearly Profit, Operating, Gross MarginsCNK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CNK Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CNK is destroying value.
  • The number of shares outstanding for CNK has been reduced compared to 1 year ago.
  • Compared to 5 years ago, CNK has less shares outstanding
  • CNK has a better debt/assets ratio than last year.
CNK Yearly Shares OutstandingCNK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
CNK Yearly Total Debt VS Total AssetsCNK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

  • CNK has an Altman-Z score of 1.40. This is a bad value and indicates that CNK is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of CNK (1.40) is comparable to the rest of the industry.
  • CNK has a debt to FCF ratio of 11.21. This is a negative value and a sign of low solvency as CNK would need 11.21 years to pay back of all of its debts.
  • The Debt to FCF ratio of CNK (11.21) is better than 63.29% of its industry peers.
  • CNK has a Debt/Equity ratio of 4.84. This is a high value indicating a heavy dependency on external financing.
  • CNK has a Debt to Equity ratio of 4.84. This is in the lower half of the industry: CNK underperforms 75.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.84
Debt/FCF 11.21
Altman-Z 1.4
ROIC/WACC0.85
WACC8.88%
CNK Yearly LT Debt VS Equity VS FCFCNK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • CNK has a Current Ratio of 0.71. This is a bad value and indicates that CNK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CNK has a worse Current ratio (0.71) than 63.29% of its industry peers.
  • A Quick Ratio of 0.67 indicates that CNK may have some problems paying its short term obligations.
  • CNK has a worse Quick ratio (0.67) than 65.82% of its industry peers.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.67
CNK Yearly Current Assets VS Current LiabilitesCNK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CNK Growth Analysis

3.1 Past

  • The earnings per share for CNK have decreased strongly by -35.47% in the last year.
  • The Revenue has been growing slightly by 2.15% in the past year.
  • CNK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 35.33% yearly.
EPS 1Y (TTM)-35.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-51.52%
Revenue 1Y (TTM)2.15%
Revenue growth 3Y8.26%
Revenue growth 5Y35.33%
Sales Q2Q%-4.67%

3.2 Future

  • Based on estimates for the next years, CNK will show a very strong growth in Earnings Per Share. The EPS will grow by 25.71% on average per year.
  • CNK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.21% yearly.
EPS Next Y56.94%
EPS Next 2Y34.8%
EPS Next 3Y25.71%
EPS Next 5YN/A
Revenue Next Year9.38%
Revenue Next 2Y6.49%
Revenue Next 3Y5.5%
Revenue Next 5Y5.21%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CNK Yearly Revenue VS EstimatesCNK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
CNK Yearly EPS VS EstimatesCNK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 -4

More info and screens

Find the best growth stocksShow best growing peers

8

4. CNK Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 23.18, the valuation of CNK can be described as rather expensive.
  • Based on the Price/Earnings ratio, CNK is valued cheaper than 87.34% of the companies in the same industry.
  • CNK's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.86.
  • With a Price/Forward Earnings ratio of 14.77, CNK is valued correctly.
  • Based on the Price/Forward Earnings ratio, CNK is valued cheaper than 88.61% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 37.39, CNK is valued rather cheaply.
Industry RankSector Rank
PE 23.18
Fwd PE 14.77
CNK Price Earnings VS Forward Price EarningsCNK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 84.81% of the companies in the same industry are more expensive than CNK, based on the Enterprise Value to EBITDA ratio.
  • CNK's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CNK is cheaper than 83.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.02
EV/EBITDA 9.54
CNK Per share dataCNK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • CNK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CNK may justify a higher PE ratio.
  • A more expensive valuation may be justified as CNK's earnings are expected to grow with 25.71% in the coming years.
PEG (NY)0.41
PEG (5Y)N/A
EPS Next 2Y34.8%
EPS Next 3Y25.71%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. CNK Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.17%, CNK has a reasonable but not impressive dividend return.
  • CNK's Dividend Yield is rather good when compared to the industry average which is at 9.59. CNK pays more dividend than 88.61% of the companies in the same industry.
  • Compared to the average S&P500 Dividend Yield of 1.82, CNK is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.17%

5.2 History

  • The dividend of CNK decreases each year by -22.38%.
  • CNK has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-22.38%
Div Incr Years0
Div Non Decr Years0
CNK Yearly Dividends per shareCNK Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • CNK pays out 28.50% of its income as dividend. This is a sustainable payout ratio.
DP28.5%
EPS Next 2Y34.8%
EPS Next 3Y25.71%
CNK Yearly Income VS Free CF VS DividendCNK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M
CNK Dividend Payout.CNK Dividend Payout, showing the Payout Ratio.CNK Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CNK Fundamentals: All Metrics, Ratios and Statistics

CINEMARK HOLDINGS INC

NYSE:CNK (4/10/2026, 8:14:30 PM)

After market: 30.3 -0.07 (-0.23%)

30.37

-0.5 (-1.62%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-18
Earnings (Next)05-01
Inst Owners111.1%
Inst Owner Change0.01%
Ins Owners2.46%
Ins Owner Change-0.06%
Market Cap3.55B
Revenue(TTM)3.12B
Net Income(TTM)136.50M
Analysts77.65
Price Target32.56 (7.21%)
Short Float %10.81%
Short Ratio4.62
Dividend
Industry RankSector Rank
Dividend Yield 1.17%
Yearly Dividend0.33
Dividend Growth(5Y)-22.38%
DP28.5%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-03
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.64%
Min EPS beat(2)-47.96%
Max EPS beat(2)77.24%
EPS beat(4)1
Avg EPS beat(4)-21.47%
Min EPS beat(4)-100.53%
Max EPS beat(4)77.24%
EPS beat(8)4
Avg EPS beat(8)57.37%
EPS beat(12)7
Avg EPS beat(12)52.05%
EPS beat(16)7
Avg EPS beat(16)-5.3%
Revenue beat(2)1
Avg Revenue beat(2)-1.19%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)0.25%
Revenue beat(4)1
Avg Revenue beat(4)-1.01%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)0.25%
Revenue beat(8)5
Avg Revenue beat(8)1.06%
Revenue beat(12)9
Avg Revenue beat(12)2.23%
Revenue beat(16)12
Avg Revenue beat(16)1.94%
PT rev (1m)0.89%
PT rev (3m)-4.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-55.12%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.04%
Revenue NQ rev (1m)0.9%
Revenue NQ rev (3m)-4.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.92%
Valuation
Industry RankSector Rank
PE 23.18
Fwd PE 14.77
P/S 1.14
P/FCF 20.02
P/OCF 8.96
P/B 8.75
P/tB N/A
EV/EBITDA 9.54
EPS(TTM)1.31
EY4.31%
EPS(NY)2.06
Fwd EY6.77%
FCF(TTM)1.52
FCFY5%
OCF(TTM)3.39
OCFY11.17%
SpS26.67
BVpS3.47
TBVpS-9.77
PEG (NY)0.41
PEG (5Y)N/A
Graham Number10.11
Profitability
Industry RankSector Rank
ROA 3.08%
ROE 33.69%
ROCE 9.53%
ROIC 7.53%
ROICexc 8.33%
ROICexgc 15.93%
OM 10.97%
PM (TTM) 4.38%
GM 64.13%
FCFM 5.69%
ROA(3y)4.3%
ROA(5y)-0.12%
ROE(3y)48.19%
ROE(5y)-45.43%
ROIC(3y)7.42%
ROIC(5y)N/A
ROICexc(3y)9.28%
ROICexc(5y)N/A
ROICexgc(3y)19.09%
ROICexgc(5y)N/A
ROCE(3y)9.39%
ROCE(5y)N/A
ROICexgc growth 3Y70.09%
ROICexgc growth 5YN/A
ROICexc growth 3Y67.55%
ROICexc growth 5YN/A
OM growth 3Y51.8%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5Y-0.48%
F-Score5
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 4.84
Debt/FCF 11.21
Debt/EBITDA 3.61
Cap/Depr 108.42%
Cap/Sales 7.03%
Interest Coverage 2.39
Cash Conversion 72.85%
Profit Quality 129.82%
Current Ratio 0.71
Quick Ratio 0.67
Altman-Z 1.4
F-Score5
WACC8.88%
ROIC/WACC0.85
Cap/Depr(3y)85.38%
Cap/Depr(5y)67.72%
Cap/Sales(3y)5.62%
Cap/Sales(5y)5.54%
Profit Quality(3y)130.93%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-51.52%
EPS Next Y56.94%
EPS Next 2Y34.8%
EPS Next 3Y25.71%
EPS Next 5YN/A
Revenue 1Y (TTM)2.15%
Revenue growth 3Y8.26%
Revenue growth 5Y35.33%
Sales Q2Q%-4.67%
Revenue Next Year9.38%
Revenue Next 2Y6.49%
Revenue Next 3Y5.5%
Revenue Next 5Y5.21%
EBIT growth 1Y-5.68%
EBIT growth 3Y64.35%
EBIT growth 5YN/A
EBIT Next Year100%
EBIT Next 3Y29.44%
EBIT Next 5Y17.33%
FCF growth 1Y-43.78%
FCF growth 3Y91.33%
FCF growth 5YN/A
OCF growth 1Y-15%
OCF growth 3Y42.81%
OCF growth 5YN/A

CINEMARK HOLDINGS INC / CNK Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CINEMARK HOLDINGS INC (CNK) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CNK.


What is the valuation status of CINEMARK HOLDINGS INC (CNK) stock?

ChartMill assigns a valuation rating of 8 / 10 to CINEMARK HOLDINGS INC (CNK). This can be considered as Undervalued.


What is the profitability of CNK stock?

CINEMARK HOLDINGS INC (CNK) has a profitability rating of 7 / 10.


What is the valuation of CINEMARK HOLDINGS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CINEMARK HOLDINGS INC (CNK) is 23.18 and the Price/Book (PB) ratio is 8.75.


How financially healthy is CINEMARK HOLDINGS INC?

The financial health rating of CINEMARK HOLDINGS INC (CNK) is 3 / 10.